Newtyn Management, LLC - Q1 2020 holdings

$290 Million is the total value of Newtyn Management, LLC's 50 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 58.6% .

 Value Shares↓ Weighting
PCG SellPG&E CORP$16,632,000
-60.3%
1,850,000
-51.9%
5.73%
+48.1%
SKY SellSKYLINE CHAMPION CORPORATION$9,408,000
-52.5%
600,000
-4.0%
3.24%
+77.0%
SPY SellSPDR S&P 500 ETF TRput$7,733,000
-93.2%
30,000
-91.5%
2.66%
-74.6%
SellTILRAY INCnote 5.000%10/0$7,590,000
-73.5%
23,000,000
-57.4%
2.61%
-1.1%
RFL SellRAFAEL HLDGS INC$5,268,000
-35.8%
411,277
-10.6%
1.81%
+139.2%
CAAP SellCORPORACION AMER ARPTS S A$3,700,000
-72.0%
2,000,000
-9.1%
1.27%
+4.5%
SRACU SellSTABLE RD ACQUISITION CORPunit 05/15/2026$3,430,000
-66.7%
350,000
-65.0%
1.18%
+24.2%
UEPS SellNET 1 UEPS TECHNOLOGIES INC$3,328,000
-56.4%
1,143,687
-44.2%
1.15%
+62.8%
CUBI SellCUSTOMERS BANCORP INC$2,669,000
-79.1%
244,203
-54.4%
0.92%
-21.9%
FWP SellFORWARD PHARMA A/Ssponsord ads new$1,979,000
-28.5%
340,599
-20.2%
0.68%
+166.0%
TRWH SellTWIN RIV WORLDWIDE HLDGS INC$1,366,000
-93.5%
105,000
-87.3%
0.47%
-75.9%
PCG SellPG&E CORPcall$526,000
-98.7%
58,500
-98.5%
0.18%
-95.3%
BXRX ExitBAUDAX BIO INC$0-278,370
-100.0%
-0.18%
TLRY ExitTILRAY INC$0-205,100
-100.0%
-0.32%
TBPH ExitTHERAVANCE BIOPHARMA INC$0-173,300
-100.0%
-0.41%
PDLI ExitPDL BIOPHARMA INC$0-1,500,000
-100.0%
-0.45%
THCAU ExitTUSCAN HLDGS CORP IIunit 04/01/2026$0-770,000
-100.0%
-0.72%
PTON ExitPELOTON INTERACTIVE INC$0-300,000
-100.0%
-0.79%
TLRY ExitTILRAY INCput$0-500,000
-100.0%
-0.79%
SSPK ExitSILVER SPIKE ACQUISITION COR$0-875,000
-100.0%
-0.80%
THCB ExitTUSCAN HOLDINGS CORP$0-985,000
-100.0%
-0.91%
ADNT ExitADIENT PLCcall$0-800,000
-100.0%
-1.57%
ATGE ExitADTALEM GLOBAL ED INC$0-626,000
-100.0%
-2.02%
CTVA ExitCORTEVA INC$0-750,000
-100.0%
-2.05%
EXAS ExitEXACT SCIENCES CORP$0-250,000
-100.0%
-2.14%
IAC ExitIAC INTERACTIVECORP$0-121,516
-100.0%
-2.80%
LSXMA ExitLIBERTY MEDIA CORP DELAWARE$0-705,000
-100.0%
-3.15%
ADNT ExitADIENT PLCput$0-1,871,000
-100.0%
-3.67%
IWM ExitISHARES TRput$0-2,094,500
-100.0%
-32.05%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC33Q2 202124.0%
NI HLDGS INC27Q3 20232.9%
ADIENT PLC26Q1 202317.3%
MERRIMACK PHARMACEUTICALS IN25Q3 20235.7%
PG&E CORP24Q3 202319.2%
SPECTRUM BRANDS HLDGS INC NE21Q3 20236.7%
RAFAEL HLDGS INC18Q2 20227.4%
CUSTOMERS BANCORP INC18Q1 20233.7%
BRISTOW GROUP INC14Q3 20234.8%
APPLIED OPTOELECTRONICS INC14Q3 20212.2%

View Newtyn Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Newtyn Management, LLC Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20231,206,5025.3%
Garrett Motion Inc.February 14, 20221,571,4512.4%
Flexion Therapeutics IncNovember 24, 20214,400,0008.7%
FLOTEK INDUSTRIES INC/CN/February 16, 20212,789,0593.8%
Forward Pharma A/SSold outFebruary 16, 202100.0%
Pfenex Inc.October 02, 2020650,0001.9%
CymaBay Therapeutics, Inc.Sold outFebruary 14, 202000.0%
Recro Pharma, Inc.Sold outFebruary 14, 202000.0%
Stable Road Acquisition Corp.February 14, 2020700,0003.9%
CSW INDUSTRIALS, INC.February 14, 2017330,0002.1%

View Newtyn Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G2024-03-08
SC 13D/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13D/A2024-02-13

View Newtyn Management, LLC's complete filings history.

Compare quarters

Export Newtyn Management, LLC's holdings